Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium hyaluronate (Laboratorios Sophia)
- Development stage
- Unknown
- Lead developer
- Laboratorios Sophia
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Lagricel Ofteno® is a preservative-free ophthalmic solution containing sodium hyaluronate (0.4%), developed by Laboratorios Sophia. It is a high molecular weight viscoelastic polymer that acts as an artificial tear and ocular lubricant. By supplementing the natural tear film, it provides long-lasting lubrication, reduces friction from blinking, and promotes corneal epithelial healing. It is primarily indicated for the treatment of dry eye disease (dry eye syndrome), post-surgical ocular recovery (such as after corneal or cataract surgery), and eye irritation associated with contact lens use.
- Brand names
- LagricelLagricel OftenoLagricel Ofteno PFLagricel PF
- Other names
- hyaluronanhyaluronate sodiumhyaluronic acidhyaluronic acid sodiumhyaluronic acid sodium salt
02
Targets
CD44 (CD44 antigen)HMMRICAM1 (Intercellular Adhesion Molecule 1)LYVE1 (Lymphatic vessel endothelial hyaluronic acid receptor 1)
Beyond the preview
Go deeper on sodium hyaluronate (Laboratorios Sophia).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium hyaluronate (Laboratorios Sophia).